IFS Advisors »

Crispr Therapeutics shares owned by IFS Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by IFS Advisors from 13F filings

Historical chart of IFS Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by IFS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by IFS Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.8k 59 64.80
2025-06-30 $2.9k 59 48.63
2025-03-31 $2.0k 59 34.02

More positions owned by IFS Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Core Dividend Growth Etf Etf (DGRO)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Ishares Ibonds Dec 2026 Term Corporate Etf Etf (IBDR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Core S&p Small Cap Etf Etf (IJR)
Vanguard Total Bond Market Etf Etf (BND)
Invesco Bulletshares 2026 Corporate Bond Etf Etf (BSCQ)
Vanguard Mid-cap Etf Etf (VO)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Ishares Treasury Floating Rate Bond Etf Etf (TFLO)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Schwab U.s. Small-cap Etf Etf (SCHA)

View all positions for IFS Advisors

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics